MedPath

BIOTHERYX, INC.

BIOTHERYX, INC. logo
🇺🇸United States
Ownership
Holding
Established
2007-01-01
Employees
11
Market Cap
-
Website
http://www.biotheryx.com

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (100.0%)

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer

Phase 1
Recruiting
Conditions
Breast Cancer
Interventions
First Posted Date
2024-07-23
Last Posted Date
2025-06-06
Lead Sponsor
Biotheryx, Inc.
Target Recruit Count
82
Registration Number
NCT06515470
Locations
🇺🇸

Biotheryx Investigative Site, Fairfax, Virginia, United States

A Study of BTX-1188 in Subjects With Advanced Malignancies

Phase 1
Terminated
Conditions
Advanced Solid Tumor
Non Hodgkin Lymphoma
Acute Myeloid Leukemia
Interventions
First Posted Date
2021-12-03
Last Posted Date
2023-09-18
Lead Sponsor
Biotheryx, Inc.
Target Recruit Count
8
Registration Number
NCT05144334
Locations
🇺🇸

City of Hope Medical Center, Duarte, California, United States

🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

🇺🇸

The Christ Hospital, Cincinnati, Ohio, United States

and more 1 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.